Grass G M, Robinson J R
University of Wisconsin-Madison 53706.
J Pharm Sci. 1988 Jan;77(1):3-14. doi: 10.1002/jps.2600770103.
Corneal penetration studies were conducted in unanesthetized albino rabbits using various organic compounds representing both polar and nonpolar species. Very low molecular weight compounds demonstrate rapid uptake into the aqueous humor despite the lipid-like barrier imposed by the corneal epithelium. Evidence that these compounds may have access to a diffusional channel for corneal transport is presented. In vitro permeability studies were also conducted in an effort to quantitate the corneal diffusion of compounds covering a range of molecular weights and partition coefficients; the results corresponded well with the results of in vivo experiments. Calculations of energies of activation, taken from Arrhenius plots, indicate that the diffusion of drug across the cornea may be by two different mechanisms that depend on the physical-chemical characteristics of the perfusant. One mechanism appears similar to drug movement in an aqueous environment and is characterized by an activation energy similar to that for diffusion in water. The other relates to the expected partitioning of a compound across cellular membranes represented by a relatively high activation energy for diffusion. For hyrdophilic compounds, the epithelium appears to be rate limiting to drug movement, whereas for hydrophobic compounds, the stroma is rate limiting. In the presence of calcium-chelating agents, glycerol demonstrated an increase in corneal penetration in vivo. This effect appears to be reversible at specific concentrations of chelator. In contrast, divalent cations reduced corneal penetration of glycerol. The known calcium chelator EDTA was shown to penetrate the cornea, conjunctiva, and iris/ciliary body from a topically applied dose. The implications of this observation pertain to toxicity effects when EDTA is incorporated into ocular drug products for stability purposes, or novel stratagems for improving ocular bioavailability of topically applied drugs are employed. The addition of calcium-chelating agents to in vivo mounted corneas demonstrated increases in permeability of the cornea to glycerol which were directly related to the concentration of chelating agent used. These results paralleled the findings of similar in vivo studies. The results of these studies are consistent with a currently proposed 'pore' model for the penetration of drugs through the cornea which demonstrates both a partition coefficient and molecular weight dependency on the permeability of the cornea to transported compounds.
使用代表极性和非极性物种的各种有机化合物,在未麻醉的白化兔中进行了角膜渗透研究。尽管角膜上皮形成了类似脂质的屏障,但极低分子量的化合物仍能迅速被吸收进入房水。本文提供了这些化合物可能通过扩散通道进行角膜转运的证据。还进行了体外渗透性研究,以定量一系列分子量和分配系数的化合物的角膜扩散;结果与体内实验结果非常吻合。根据阿伦尼乌斯图计算的活化能表明,药物穿过角膜的扩散可能通过两种不同的机制,这取决于灌注液的物理化学特性。一种机制似乎类似于药物在水性环境中的移动,其特征是活化能与在水中扩散的活化能相似。另一种机制与化合物在细胞膜上的预期分配有关,其特征是扩散的活化能相对较高。对于亲水性化合物,上皮似乎是药物移动的限速因素,而对于疏水性化合物,基质是限速因素。在存在钙螯合剂的情况下,甘油在体内的角膜渗透率有所增加。在特定浓度的螯合剂下,这种效应似乎是可逆的。相比之下,二价阳离子降低了甘油的角膜渗透率。已知的钙螯合剂乙二胺四乙酸(EDTA)经局部给药后可穿透角膜、结膜和虹膜/睫状体。当将EDTA用于眼部药物产品以提高稳定性,或采用改善局部应用药物眼部生物利用度的新策略时,这一观察结果的意义涉及毒性作用。向体内安装的角膜中添加钙螯合剂可使角膜对甘油的渗透率增加,这与所用螯合剂的浓度直接相关。这些结果与类似体内研究的结果一致。这些研究结果与目前提出的药物通过角膜渗透的“孔”模型一致,该模型表明分配系数和分子量对角膜对转运化合物的渗透率均有依赖性。